• 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Preventive Medicine: An International Journal Devoted to Practice and Theory >Completion and timing of the three-dose human papillomavirus vaccine series among adolescents attending school-based health centers in Oregon.
【24h】

Completion and timing of the three-dose human papillomavirus vaccine series among adolescents attending school-based health centers in Oregon.

机译：在俄勒冈州以学校为基础的医疗中心的青少年中，三剂人乳头瘤病毒疫苗系列的完成和时间安排。

获取原文
获取原文并翻译 | 示例
       
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

OBJECTIVE: Many adolescents do not complete the 3-dose human papillomavirus vaccine series in the recommended time frame, or at all. Given the challenges of administering a multi-dose vaccine to adolescents, especially those in vulnerable populations, we evaluated completion of the human papillomavirus vaccine series in 19 of Oregon's school-based health centers. METHODS: Among persons aged 0-17 who initiated the human papillomavirus vaccine series at a study school-based health center in 2007, we identified all subsequent human papillomavirus doses administered at the school-based health centers, or found in Oregon's immunization information system, in 2007-2008. We describe the proportion completing the vaccine series and mean intervals between doses, stratified by age, race, and insurance status. RESULTS: Four hundred fifty persons initiated the human papillomavirus series in 2007. By December 2008, 51% of these had received all 3 doses. Series completion increased significantly with age, differed significantly between race groups (highest among white persons (56%); lowest among black persons (38%)), and did not differ significantly by insurance status. Mean intervals between doses did not differ significantly by race or insurance status. CONCLUSIONS: Even in challenging conditions, school-based health centers provide excellent preventive care to vulnerable youth. These results support the importance of maintaining and expanding school-based health center access in vulnerable adolescent populations.
机译：目的：许多青少年在建议的时间范围内或根本没有完成3剂量的人乳头瘤病毒疫苗系列。鉴于向青少年（尤其是弱势人群）施用多剂疫苗面临的挑战，我们在俄勒冈州的19个校内医疗中心评估了人类乳头瘤病毒疫苗系列的完成情况。方法：在2007年于学校健康中心发起人乳头瘤病毒疫苗系列的0-17岁人群中，我们确定了在学校健康中心或俄勒冈州免疫信息系统中发现的所有后续人乳头瘤病毒剂量，在2007-2008年。我们描述了完成疫苗系列的比例和剂量之间的平均间隔，并按年龄，种族和保险状况进行了分层。结果：2007年有450人启动了人类乳头瘤病毒系列试验。到2008年12月，其中51％的人接受了全部3剂。比赛完成率随着年龄的增长而显着增加，种族之间的差异也很大（白人最高（56％）;黑人最低（38％）），并且保险状况也没有显着差异。两次剂量之间的平均间隔在种族或保险状况方面没有显着差异。结论：即使在充满挑战的条件下，以学校为基础的保健中心也可以为脆弱的年轻人提供出色的预防保健。这些结果支持了在脆弱的青少年人群中维持和扩大基于学校的保健中心的重要性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号